NOV Inc. (NOV) — Fair Value Analysis

Base-case fair value (P50): $22.43 · Current price: $19.43 · Verdict: Undervalued

The Verdict on NOV

NOV INC (NOV) is currently assessed as Fairly Valued according to our proprietary Monte Carlo simulations. With NOV trading at $19.43, our P50 median fair value stands at $22.43. This indicates an +15.4% potential upside from the current price, placing it squarely within a reasonable valuation range based on our forward-looking model. Investors seeking clarity on whether NOV is overvalued can view this modest upside as an indication that the market is currently pricing the stock efficiently given its fundamentals and future prospects. This "Fairly Valued" verdict suggests that the market's current assessment aligns closely with the probabilistic outcomes derived from our extensive simulations, which factor in a myriad of variables impacting the company's future cash flows and market position.

How NOV stacks up against peers

NOV's operational and financial health is currently deemed average compared to its sector. This quality tier suggests that while NOV is not facing significant immediate distress, it also doesn't exhibit the superior competitive advantages or financial resilience seen in top-tier performers. The average quality tier is an integral factor within our Monte Carlo simulations, influencing the range of potential outcomes and the overall probability distribution. Our models account for this average standing by incorporating relevant sector benchmarks and intrinsic risk factors. Consequently, our fair value assessment of $22.43 for a company with an average quality tier reflects a balanced outlook, incorporating both its current market position and potential future performance trajectories, without assuming outsized growth or exceptional resilience.

What this means for investors

For investors considering NOV at its current price of $19.43, the "Fairly Valued" verdict suggests a balanced risk-reward profile. The Monte Carlo analysis projects a median fair value of $22.43, implying an +15.4% upside. While this doesn't signal significant undervaluation, it indicates that current prices are justified by fundamental drivers. Investors should recognize that an average quality tier can lead to a broader range of outcomes in both bull and downside scenarios compared to higher-quality firms. To understand the full probabilistic distribution, including detailed bear and bull case targets, and to track NOV's fair value as new fundamentals are released, sign up for a free FairCurve account.